Increased Nasopharyngeal Bacterial Titers and Local Inflammation Facilitate Transmission of Streptococcus pneumoniae by Short, K.R. et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
Increased Nasopharyngeal Bacterial Titers and Local Inflammation
Facilitate Transmission of Streptococcus pneumoniae
Kirsty R. Short,a Patrick C. Reading,a,b Nancy Wang,a Dimitri A. Diavatopoulos,c and Odilia L. Wijburga
Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Victoria, Australiaa; WHO Collaborating Centre for Reference and Research on
Influenza, Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australiab; and Laboratory of Pediatric Infectious Diseases, Department of Pediatrics,
Radboud University Medical Centre, Nijmegen, The Netherlandsc
ABSTRACT The transmission of the bacterium Streptococcus pneumoniae (the pneumococcus) marks the first step toward disease
development. To date, our ability to prevent pneumococcal transmission has been limited by our lack of understanding regard-
ing the factors which influence the spread of this pathogen.We have previously developed an infant mouse model of pneumo-
coccal transmission which was strictly dependent on influenza A virus (IAV) coinfection of both the experimentally colonized
“index mice” and the naive cohoused “contact mice.” Here, we sought to use this model to further elucidate the factors which
facilitate S. pneumoniae transmission. In the present report, we demonstrate that increasing the nasopharyngeal load of S. pneu-
moniae in the colonized index mice (via the depletion of neutrophils) and inducing a proinflammatory response in the naive co-
housed contact mice (as demonstrated by cytokine production) facilitates S. pneumoniae transmission. Thus, these data provide
the first insights into the factors that help mediate the spread of S. pneumoniae throughout the community.
IMPORTANCE Streptococcus pneumoniae (the pneumococcus) is a major cause of worldwide morbidity and mortality and is a
leading cause of death among children under the age of five years. Transmission of S. pneumoniaemarks the first step toward
disease development. Therefore, understanding the factors that influence the spread of pneumococci throughout the community
plays an essential role in preventing pneumococcal disease. We previously developed the first reproducible infant mouse model
for pneumococcal transmission and showed that coinfection with influenza virus facilitates the spread of S. pneumoniae. Here,
we show that increasing the bacterial load in the nasal cavity of colonized individuals as well as inducing an inflammatory re-
sponse in naive “contact cases” facilitates the spread of pneumococci. Therefore, this study helps to identify the factors which
must be inhibited in order to successfully prevent pneumococcal disease.
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Streptococcus pneumoniae (the pneumococcus) is a respiratorypathogen that colonizes the nasopharynx of up to 80% of chil-
dren (1, 2). Following colonization of the nasopharynx, S. pneu-
moniae can disseminate to the lung, brain, blood, or middle ear,
causing pneumonia, meningitis, sepsis, and otitis media, respec-
tively. Children suffer a large burden of pneumococcal disease,
and each year this bacterium kills up to 1 million children under
the age of five years (3). Nasopharyngeal colonization with
S. pneumoniae marks the first step toward the development of
pneumococcal disease (2, 4). Therefore, understanding and pre-
venting the spread of the pneumococcus plays a crucial role in
maintaining public health.
Pneumococcal transmission occurs via contact with the respi-
ratory secretions and saliva of colonized individuals either directly
via the inhalation of bacteria or indirectly via contact with con-
taminated surfaces (2, 5). Several studies have provided evidence
for the importance of close person-to-person contact (e.g. at day
care centers) in the spread of pneumococci (6, 7). A viral infection
of the respiratory tract is also associated with the transmission of
S. pneumoniae in humans. For example, the horizontal transmis-
sion of S. pneumoniae among familymembers has been linked to a
concurrent viral infection of the respiratory tract (8). Similarly,
infection with the pandemic 2009 influenza A virus (IAV) was
associated with the household transmission of S. pneumoniae (9).
The mechanisms by which IAV coinfection may facilitate pneu-
mococcal transmission remain unclear. IAV increases pneumo-
coccal titers in the nasopharynx (10–13), potentially facilitating
transmission by then increasing the shedding of this bacterium
into the community. Alternatively, IAV is known to suppress spe-
cific components of the immune response whichmay then predis-
pose individuals to acquire S. pneumoniae from colonized indi-
viduals. Virus-induced inflammation may also facilitate
pneumococcal transmission, as inflammation can upregulate re-
ceptors for pneumococcal adherence (14–17).
Thus, while epidemiological studies have provided insights
into the factors associated with pneumococcal transmission, few
studies have demonstrated the contribution of these factors to the
spread of S. pneumoniae in a defined experimental setting. Using
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infant mice tomimic the underdeveloped immune system of chil-
dren, we have previously shown that coinfection with IAV facili-
tated the transmission of S. pneumoniae (13), consistent with sub-
sequent studies in ferrets (18). In this model, influenza virus had
an effect on both the “index mice” (i.e., those colonized with
S. pneumoniae) and the cohoused, previously naive, “contact
mice” (13). Here, we sought to use this model to further elucidate
the factors which facilitate pneumococcal transmission from the
index to the contact mice.
RESULTS
Multiple influenza virus strains facilitate pneumococcal trans-
mission.Wepreviously demonstrated that infection with the IAV
strain Udorn/72 facilitated pneumococcal transmission, provided
that both the index and contact mice were infected with IAV (13).
In order to further assess the factors which contribute to the
spread of S. pneumoniae, we determined whether multiple strains
of IAV facilitated pneumococcal transmission. Five-day-old index
mice were colonized with S. pneumoniae and cohoused with un-
infected contact mice. At 14 days of age, the index mice were
infected with IAV; 6 days later, the transmission of S. pneumoniae
from the index to the contact mice was determined (Fig. 1A). We
have previously found that the IAV Udorn/72 strain itself also
efficiently transmits between cohoused mice (13). The experi-
mental setup used here was therefore based upon the assumption
FIG 1 Multiple IAV (influenza A virus) strains facilitate pneumococcal transmission. (A and C) The experimental model used to assess pneumococcal
transmission. In brief, at 5 days of age, pups were randomly distributed into two groups of equal size ( one mouse). One group, designated index mice, was
colonized with S. pneumoniae (indicated by the black mice). The index mice were then returned to, and cohoused in the same cage as, the remaining,
noncolonized pups (contact mice; indicated by the white mice). At 14 days of age, either only the index mice (A) or both the index and contact mice (C) were
infected with IAV. Six days later, transmission of S. pneumoniae from the index to the contact mice was assessed. (B) Pneumococcal and IAV transmission
following infectionof indexmicewithdifferent strainsof IAV. (D)Pneumococcal andIAVtransmission following infectionofboth indexandcontactmicewithdifferent
strains of IAV. Data were pooled from aminimum of two independent experiments and represent numbers of infected contact mice/total numbers of contact mice.
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that, like Udorn/72, other IAV strains would also transmit be-
tweenmice. Similar to our previous finding (13), there was little to
no transmission of pneumococci to the contact mice in the ab-
sence of IAV (Fig. 1B; “Mock” treatment group). Infection with
HKx31 and Port Chalmers/73 facilitated pneumococcal transmis-
sion (Fig. 1B). Accordingly, these virus strains themselves also
transmitted between mice (Fig. 1B). In contrast, IAV strains
PR8/34 and Brazil/78 did not transmit efficiently to contact ani-
mals. Limited pneumococcal transmission also occurred in these
mice (Fig. 1B). To investigate whether this was due to an intrinsic
defect of these IAV strains with respect to facilitating pneumococ-
cal transmission, we performed experiments in which all mice
were infected with PR8/34 or Brazil/78 (Fig. 1C). In these experi-
ments, we observed successful pneumococcal transmission
(Fig. 1D), suggesting that multiple different IAV strains facilitate
the spread of S. pneumoniae provided that both the index and
contact mice are efficiently infected with IAV.
Increased nasopharyngeal bacterial titers in the index mice
facilitated pneumococcal transmission. In both children and in-
fant mice, IAV increases pneumococcal titers in the nasal cavity
(11, 13), andwe reasoned that an increased bacterial loadmay play
an important role in pneumococcal transmission.We thus sought
to increase the pneumococcal load independently of a viral infec-
tion and to assess whether this was sufficient to facilitate pneumo-
coccal transmission. In infant mice, increasing the infectious dose
is not sufficient to increase the load of pneumococci in the nasal
cavity, as following colonization the bacterial load in the nose
rapidly plateaus to the same titer, even when the infectious dose is
increased by 1,000-fold (data not shown). Similarly, while intra-
nasal treatment with sialic acid increases pneumococcal coloniza-
tion in adult mice (19), this treatment did not affect pneumococ-
cal titers in the nose of infant mice (data not shown). Instead, we
chose to deplete neutrophils in the index mice, as neutrophils are
thought to be important in controlling pneumococcal coloniza-
tion (20). Intraperitoneal and intranasal treatment with the
neutrophil-depleting 1A8 monoclonal antibody (MAb) resulted
in an approximately 90% depletion of neutrophils in the nasal
turbinate relative to treatment with the control antibody (see
Fig. S1 in the supplemental material). Treatment with 1A8 also
resulted in a small but significant increase in the numbers of pneu-
mococci in the nasal cavity whichwas comparable to the increased
load detected after infection with the PR8/34, Udorn/72, and
HKx31 IAV strains (Fig. 2A and B).
We then investigated if neutrophil depletion and the associated
increase in pneumococcal load were sufficient to facilitate pneu-
mococcal transmission to susceptible contact mice. Neutrophils
were depleted from 14-day-old S. pneumoniae-colonized index
mice by treatment with MAb 1A8. In order to ensure that the
contact mice were in an “acquisition-ready” state, 14-day-old
contact mice were infected with IAV (Fig. 2C). For these experi-
ments, contact mice were infected with the PR8/34 strain, as the
experiments described above demonstrated that this strain does
not readily transmit itself between cohousedmice (Fig. 1B).When
the index mice were treated with the control antibody, pneumo-
coccal transmission was not observed (Fig. 2C). However, when
neutrophils were depleted in the index mice there was a signifi-
cantly higher transmission rate (53%) compared to the rate seen
with mice treated with the control antibody (Fig. 2C; Fischer’s
exact test; P 0.05). This transmission rate was not significantly
different from the 78% transmission rate observed when all mice
were infected with PR8/34 (Fig. 1D; Fischer’s exact test; P 0.05).
The pneumococcal titers in the nose of the contact mice showed
substantial variation (see Fig. S2 in the supplemental material), as
the titers depend uponwhich day the contactmice acquired pneu-
mococci from cohoused index mice. That is, mice that acquired
pneumococci early from the index mice would have already
reached the “plateau level” at the time of euthanasia, while mice
that had just acquired pneumococci at 19 days of age would have
had markedly lower titers of S. pneumoniae. Ultimately, however,
there was a significantly higher rate of pneumococcal colonization
in the contactmice when the indexmice were treatedwith the 1A8
MAb. In summary, these data show that neutrophils play an im-
portant role in limiting pneumococcal shedding and, conse-
quently, pneumococcal transmission.
Nasopharyngeal inflammation in contactmice lowered their
threshold for acquisition of S. pneumoniae. In the contact mice,
neutrophils may also play an important role in preventing newly
acquired S. pneumoniae from attaching to the respiratory epithe-
lium, thereby restricting transmission. To assess this hypothesis,
we depleted neutrophils from 14-day-old naive contact mice by
treatment with MAb 1A8, while the colonized index mice were
coinfected with PR8/34 (Fig. 3A). As in the index mice, intraperi-
toneal and intranasal treatment of the contact mice with the
neutrophil-depleting 1A8MAb resulted in an approximately 90%
depletion of neutrophils in the nasal turbinate (see Fig. S1 in the
supplemental material). However, treatment of contact mice with
the MAb 1A8 did not significantly increase the rate of pneumo-
coccal transmission compared to contact mice treated with the
control antibody (Fig. 3B; Fischer’s exact test; P  0.05). These
data suggest that the absence of neutrophils in the contact mice
does not increase their susceptibility to pneumococcal coloniza-
tion.
Recent studies have shown that inflammation plays an impor-
tant role in the development of pneumococcal pneumonia by fa-
cilitating bacterial adhesion to epithelial cells (15). Thus, we next
examined whether the induction of a proinflammatory response
increases the susceptibility of contactmice to S. pneumoniae trans-
mission. To induce inflammation in the contact mice, mice were
treated with lipopolysaccharide (LPS), a strong proinflammatory
ligand (Fig. 3C). As with IAV infection, treatment with LPS in-
duced a proinflammatory response in the nasal cavity of contact
mice (as demonstrated by the production of selected proinflam-
matory cytokines) (Fig. 3D). In contrast, few to no proinflamma-
tory cytokines were detected in the nasal cavities of mice treated
with phosphate-buffered saline (PBS) or untreatedmice (Fig. 3D).
We then assessed if a proinflammatory response in the nose of the
contact mice was sufficient to mediate pneumococcal transmis-
sion. Contact mice treated with LPS had a 75% rate of pneumo-
coccal transmission, significantly higher than that observed in the
mice treated with PBS (Fig. 3D; Fischer’s exact test; P 0.01; see
also Fig. S3 in the supplemental material) and effectively equiva-
lent to the 78% transmission rate observed when all mice were
infected with PR8/34 (Fig. 1D). Together, these data suggest that
modulation of airway inflammation in the contact mice may rep-
resent an essential aspect of pneumococcal transmission.
DISCUSSION
The transmission of bacterial respiratory pathogens is a complex
process which depends on a variety of host, environmental, and
microbial factors. Here, we have used our recently developed
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mousemodel (13) to provide novel insights into the factors which
contribute to the spread of pneumococci.
Using a panel of different IAV strains, we showed that pneu-
mococcal transmission was not restricted to a particular IAV sub-
type and that both H1N1 and H3N2 strains facilitated bacterial
spread. Interestingly, we also observed that not all IAV stains were
able to transmit between cohousedmice. The factors which deter-
mine the transmission of IAV remain an important area for future
study. However, the extrapolation of these data suggests that the
transmission of S. pneumoniae is likely to increase during any
future IAV epidemic/pandemic, regardless of the viral strain in-
volved.
In the indexmice, we demonstrated that a small but significant
increase in pneumococcal load in the nasal cavity was sufficient to
mediate bacterial transmission to susceptible mice. In the contact
mice, an inflammatory response in the nasal cavity also facilitated
pneumococcal transmission. Given that coinfectionwith IAV also
increases the pneumococcal load in index mice and induces in-
flammation in the contact mice, it is therefore tempting to specu-
late that these represent the mechanisms by which IAV facilitates
S. pneumoniae transmission. Of course, IAV may induce addi-
tional changes in the index and contact mice, other than those
shown here, that may impact upon pneumococcal transmission.
For example, a viral infection in mice may induce changes such as
increased nasal secretions and/or altering the way in which mice
interact with their cohoused littermates. The complex and multi-
faceted nature of transmission makes it difficult to elucidate the
contribution of these additional factors in an experimental set-
ting. However, given that increasing the nasopharyngeal bacterial
load and inducing inflammation resulted in equivalent transmis-
sion rates for a viral infection, our data would suggest that these
are the predominant effects of IAV in this model. It is also likely
that any other virus/condition that allows increased pneumococ-
cal shedding and/or increased inflammation in susceptible hosts
may also favor pneumococcal spread.
While this represents the first study to demonstrate that in-
FIG 2 The effect of pneumococcal load in the index mice on S. pneumoniae transmission. (A) Titers of S. pneumoniae (Sp) in the nasal cavity 6 days after mock
infection, infection with IAV, or treatment with 1A8 or rat IgG. Statistical significance was determined using a Mann-Whitney U test accompanied by a
Bonferroni posttest, and statistical significance is denoted by one asterisk (P 0.05). Data represent the means standard errors of the means (SEM) and are
pooled from aminimumof two independent experiments. ns, not statistically significant. (B) Titers of IAV in the nasal cavity 6 days postinfection.Data represent
means SEM and were pooled from a minimum of two independent experiments. (C) Experimental design to assess the role of increased pneumococcal titers
in the index mice in S. pneumoniae transmission. In brief, at 5 days of age, pups were randomly distributed into two groups of equal size ( one mouse). One
group, designated indexmice, was colonized with S. pneumoniae (indicated by the blackmice). The indexmice were then returned to, and cohoused in the same
cage as, the remaining, noncolonized pups (contact mice; indicated by the white mice). At 14 to 19 days of age, the index mice were treated with rat IgG or the
neutrophil-depleting MAb 1A8. At 14 days of age, the contact mice were infected with IAV (strain PR8/34). Six days later, transmission of S. pneumoniae from
the index to the contact mice was assessed. (D) Pneumococcal and IAV transmission in mice 6 days postinfection/treatment. Statistical significance was
determined using Fisher’s exact test, and statistical significance is denoted by two asterisks (P 0.01). Data were pooled from aminimum of three independent
experiments.
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FIG 3 The effect of inflammation in the contact mice on pneumococcal transmission. (A) Experimental design to assess the neutrophil depletion in the contact
mice in S. pneumoniae transmission. In brief, at 5 days of age, pups were randomly distributed into two groups of equal size ( one mouse). One group,
designated index mice, was colonized with S. pneumoniae (indicated by the black mice). The index mice were then returned to, and cohoused in the same cage
as, the remaining, noncolonized pups (contact mice; indicated by the white mice). At 14 to 19 days of age, the contact mice were treated with rat IgG or the
neutrophil-depletingMAb 1A8. At 14 days of age, the index mice were infected with IAV (strain PR8/34). Six days later, transmission of S. pneumoniae from the
index to the contact mice was assessed. (B and E) Pneumococcal and IAV transmission in mice 6 days postinfection/treatment. Statistical significance was
determined using Fisher’s exact test, and statistical significance is denoted by two asterisks (P 0.01). Data were pooled from aminimum of three independent
experiments. N.S, not statistically significant. (C) Experimental design to assess the role of inflammation in the contact mice in S. pneumoniae transmission. In
brief, at 5 days of age, mice were randomly distributed into two groups of equal size ( one mouse). One group, designated index mice, was colonized with
S. pneumoniae (indicated by the blackmice). The indexmicewere then returned to, and cohoused in the same cage as, the remaining, noncolonizedmice (contact
mice; indicated by the white mice). At 14 to 19 days of age, the contact mice were treated with PBS or LPS. At 14 days of age, the index mice were infected with
IAV (strain PR8/34). Six days later, transmission of S. pneumoniae from the index to the contact mice was assessed. (D) Cytokine levels in the nasal cavity 6 days
postinfection/treatment. These experiments were performed usingmice not colonizedwith S. pneumoniae to reflect the inflammatory response that occurs in the
contact mice. Therefore, 14-day-old mice were (i) infected with PR8/34, Udorn/72, or HKx31 or (ii) treated daily with LPS or PBS from day 14 to day 19. At day
20, mice were culled and cytokine levels were determined in clarified homogenates from nasal cavity tissues. Data shown represent means  SEM. Statistical
significance (relative to naive mice) was determined using a Mann-WhitneyU test accompanied by a Bonferroni posttest, and statistical significance is denoted
by one asterisk (P 0.05), two asterisks (P 0.01), or three asterisks (P 0.001).
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creasing the load of pneumococci in the nasal cavity facilitates
pneumococcal transmission, this was not an entirely unexpected
finding. These data are consistent with previous studies demon-
strating that the titers in the index animal are important for the
transmission of other respiratory pathogens (21, 22). It is likely
that these increased titers result in increased shedding of S. pneu-
moniae to other mice and into the environment, where the bacte-
ria can survive for up to 15 h (13, 23). In the present study, deple-
tion of neutrophils was sufficient to increase the load of
pneumococci in the nasal cavity, suggesting an important role for
neutrophils in controlling pneumococcal transmission. This is in
contrast to previous observations that neutrophil depletion using
the RB6 antibody did not affect pneumococcal density in the nasal
cavity 3 days postcolonization (24). However, it must be empha-
sized that, in contrast to the present study, those studies were
performed in adult mice. As infant mice (like human children)
display different colonization dynamics compared to adult mice,
it is likely that the factors which control pneumococci in the nose
also show age-dependent variation. It is interesting to speculate on
the mechanisms by which neutrophils control pneumococcal
density. One potential explanation is that neutrophils kill S. pneu-
moniae directly following opsonophagocytosis, e.g., through ser-
ine proteases. Identifying the exact roles of neutrophils in control-
ling the mucosal density of S. pneumoniae remains an important
area of future research.
In the contact mice, the depletion of neutrophils did not affect
the rate of pneumococcal transmission. This most likely reflects
the fact that neutrophils enter the lumenof the nasal cavity in large
amounts only from 3 days post-pneumococcal colonization (2).
Therefore, it is likely that neutrophils play an important role in
controlling pneumococci in the period postcolonization, rather
than serving to prevent the initial colonization event. Instead, we
showed that a proinflammatory response in the nasal cavity was
sufficient to mediate pneumococcal transmission. There is now a
growing body of evidence to suggest that, in contrast to many
other bacterial pathogens, an inflammatory response can facilitate
both pneumococcal colonization and disease (15, 16, 25, 26). It
has been suggested that this is due to the ability of an inflamma-
tory response to upregulate receptors for pneumococci (such as
the platelet activating factor receptor [PAF-R]) (16, 17) or to ex-
pose components of the basement membrane for pneumococcal
adherence (27). These data thus support the growing body of ev-
idence that virus-induced inflammation may play an important
role in the development of pneumococcal disease. Interestingly,
treatment of the index mice with LPS did not increase pneumo-
coccal titers or facilitate pneumococcal transmission (data not
shown), suggesting that the role of inflammation in pneumococ-
cal transmission is restricted to the contact mice.
In summary, while extensive research has been performed on
the factors which contribute to the development of pneumococcal
disease, these data provide the first experimental evidence that
changes in bacterial load and inflammation in the nasal cavity
facilitate pneumococcal transmission. Given that blocking
S. pneumoniae transmission is the most effective way to prevent
pneumococcal disease in the community, our data suggest that
these factorsmust be assessed when evaluating the clinical efficacy
of novel antipneumococcus therapies and vaccines.
MATERIALS AND METHODS
Bacterial and viral strains. The S. pneumoniae EF3030 strain (type 19F)
was used in all experiments. The preparation and storage of pneumococci
prior to infection are described elsewhere (28). The panel of different IAV
strains used in this study is shown in Table 1. Virus stocks were prepared
in embryonated eggs, and titers of infectious virus were determined by
three independent plaque assays on Madin-Darby canine kidney
(MDCK) cells as described previously (28).
Infection of mice. C57BL/6 mice were bred and housed under con-
ventional conditions at the animal facility of the Department of Microbi-
ology and Immunology at the University ofMelbourne, Melbourne, Aus-
tralia, and were held under specific pathogen-free conditions. All animal
experiments were approved by the University of Melbourne Animal Eth-
ics and Experimentation Committee and complied with the Prevention of
Cruelty to Animals Act (1986) and the National Health and Medical Re-
search Council (NHMRC) Australian Code of Practice for the Care and
Use of Animals for Scientific Purposes (1997). At 5 days of age, pups were
randomly distributed into two groups of equal size ( one mouse). One
group, designated index mice, was colonized intranasally (i.n.) with 2 
103 CFU of S. pneumoniae EF3030 in a volume of 3 l. The index mice
were then returned to, and cohoused in the same cage as, the remaining,
noncolonized pups (contact mice) and dam. At 14 days of age, pups were
infected i.n. with 20 PFU (PR8/34), 104 PFU (Brazil/78), or 102.5 PFU (all
other strains) of IAV in 3l PBS. Six days later, mice were euthanized and
organs were collected for analysis.Where relevant,mice were treated daily
(days 14 to 19) i.n. with 50 g Salmonella enterica serovar Typhimurium
LPS (Sigma-Aldrich) in 10 l PBS.
Enumeration of bacterial and viral loads.Quantification of bacterial
and viral loads was performed as described previously (29). We defined
pneumococcal transmission as a contact mouse having 222 CFU/ml
detectable in the nasal cavity. Similarly, we defined viral transmission as
having occurred when 5 PFU/ml was detected in the nasal cavity or
lungs of contact mice.
Depletion of neutrophils. Neutrophils were depleted using purified
anti-Ly6G rat MAb (clone 1A8; a gift from Thomas Malek, University of
Miami). MAb 1A8 was administered intraperitoneally (i.p.) (0.3 mg) and
i.n. (0.1 mg) to mice 14 to 19 days of age. Control mice received an
equivalent dose of nonspecific rat IgG (Jackson Laboratories). To assess
the efficacy of the depletion, a series of separate experiments were per-
formed in which 5-day-old mice were colonized with 2  103 CFU of
S. pneumoniae EF3030 in a volume of 3 l of PBS. The relevant antibody
was then administered intraperitoneally (i.p.) (0.3 mg) and i.n. (0.1 mg)
daily to mice 14 to 19 days of age. When mice were 20 days of age, blood
was collected in lithium heparin tubes (BD Biosciences) and neutrophil
levels were analyzed using an Advia hematology system (Bayer). Success-
ful depletion of neutrophils in the nosewas confirmedusing fluorescence-
TABLE 1 Viral strains used
Virus name Description
Mt. Sinai strain of A/PR/8/34 (H1N1; PR8/34) Wild-type virus
A/Udorn/307/72 (H3N2; Udorn/72) Wild-type virus
A/Port Chalmers/1/73 (H3N2; Pt. Chalmers/73) Wild-type virus
A/Brazil/11/78 (H1N1; Brazil/78) Wild-type virus
HKx31 (H3N2) A high-yielding reassortant of A/PR/8/34 (H1N1) and A/Aichi/2/68 (H3N2)
Short et al.
















activated cell sorter (FACS) analysis. Briefly, the nasal turbinate was taken
from each mouse and treated in RPMI medium (Gibco Invitrogen Cor-
poration) containing 200 g/ml collagenase D (Roche, Switzerland) and
40g/ml DNase (Roche) for 30min at 37°C. Single-cell suspensions were
prepared and stained for CD45 (APC-Cy7; clone 30-F11; BDPharmigen),
CD3 (PE-Cy7; clone 145-2C11; BD Pharmigen), CD11b (fluorescein iso-
thiocyanate [FITC]; clone M1/70; BD Pharmigen), and Ly6G (phyco-
erythrin [PE]; clone IA8; BD Pharmigen). Each sample was pooled from
the nasal turbinates of 2 mice. Data were acquired on a FACSCanto II
flow cytometer (BDBiosciences) immediately after propidium iodide (PI;
Sigma-Aldrich) addition. Collected cells were analyzed with FlowJo, ver-
sion 8.8.7 (TreeStar, Inc.). Neutrophils were defined as single cells which
were PI negative (PI) CD45 Ly6G CD3 (30). The expression of
CD11b was also confirmed on PI CD45 Ly6G CD3 cells. In each
transmission experiment, depletion efficiency was confirmed by Advia
analysis of the blood and FACS analysis of the spleen (as the nose was used
for analysis of bacterial and viral titers).
Cytokine analysis. Levels of cytokines in nasal cavity homogenates
were measured using a mouse cytometric bead array (CBA) Flex Set (BD
Biosciences).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org
/lookup/suppl/doi:10.1128/mBio.00255-12/-/DCSupplemental.
Figure S1, EPS file, 1 MB.
Figure S2, EPS file, 0.6 MB.
Figure S3, EPS file, 0.6 MB.
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